Hoth Therapeutics, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2018 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Hoth Therapeutics, Inc. annual/quarterly Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2018 to Q1 2023.
  • Hoth Therapeutics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2023 was $8.91M.
  • Hoth Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $11.3M, a 87.5% increase from 2022.
  • Hoth Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $6.04M, a 66.8% decline from 2021.
  • Hoth Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $18.2M, a 109% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $8.91M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q1 2021 $18.4M +$14.2M +336% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q1 2020 $4.23M -$1.63M -27.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q1 2019 $5.86M +$4.67M +394% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q1 2018 $1.19M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.